Does the Evidence Make a Difference in Consumer Behavior? Sales of Supplements Before and After Publication of Negative Research Results
Authors:
Open Access
- 10 July 2008
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 23 (9) , 1495-1498
Abstract
Objective To determine if the public consumption of herbs, vitamins, and supplements changes in light of emerging negative evidence. Methods We describe trends in annual US sales of five major supplements in temporal relationship with publication of research from three top US general medical journals published from 2001 through early 2006 and the number of news citations associated with each publication using the Lexus-Nexis database. Results In four of five supplements (St. John’s wort, echinacea, saw palmetto, and glucosamine), there was little or no change in sales trends after publication of research results. In one instance, however, dramatic changes in sales occurred following publication of data suggesting harm from high doses of vitamin E. Conclusion Results reporting harm may have a greater impact on supplement consumption than those demonstrating lack of efficacy. In order for clinical trial evidence to influence public behavior, there needs to be a better understanding of the factors that influence the translation of evidence in the public.Keywords
This publication has 24 references indexed in Scilit:
- Use of Herbal Medicine and Other Dietary Supplements in Community‐Dwelling Older People: Baseline Data from the Ginkgo Evaluation of Memory StudyJournal of the American Geriatrics Society, 2006
- Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in ChildrenJAMA, 2003
- Clinical Research to Clinical Practice — Lost in Translation?New England Journal of Medicine, 2003
- Disseminating Innovations in Health CareJAMA, 2003
- Efficacy of St. John’s Wort Extract WS 5570 in Major Depression: A Double-Blind, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2002
- Effect of Hypericum perforatum (St John's Wort) in Major Depressive DisorderJAMA, 2002
- Efficacy and Tolerability of Hypericum Extract WS 5572 versus Placebo in Mildly to Moderately Depressed Patients - A randomized double-blind multicenter clinical trial -Pharmacopsychiatry, 2001
- Effectiveness of St John's Wort in Major DepressionJAMA, 2001
- Comparison of St John's wort and imipramine for treating depression: randomised controlled trialBMJ, 2000
- Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks Commentary: Has hypericum found its place in antidepressant treatment?BMJ, 1999